首页 > 市场调查报告书 > 医疗设备

透析机设备

市场调查报告书

商品编码

1560823

全球腹膜透析市场 - 2024 - 2031

Global Peritoneal Dialysis Market - 2024 - 2031

出版日期: 2024年09月23日 | 出版商:

DataM Intelligence | 英文 186 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

报告概述

2023年全球腹膜透析市场规模达52亿美元，预计2031年将达83亿美元，2024-2031年预测期间复合年增长率为6.0%

腹膜透析是一种治疗肾衰竭的方法，肾衰竭是肾臟无法有效过滤血液的情况。它涉及一种清洁液通过管道流入胃部区域或腹部，其中腹膜充当过滤器。经过设定的时间后，过滤后的液体将被丢弃。腹膜透析与血液透析不同，血液透析是在机器中将血液过滤到体外。治疗可以在家中、工作或旅行时进行，但并非所有肾衰竭患者都能从这种治疗中受益。成功的腹膜透析需要熟练的手部护理和值得信赖的护理人员。

市场动态：

驱动程式和限制

慢性肾臟病盛行率上升

全球 ESRD 和 CKD 发生率的上升是主要驱动因素之一。随着需要透析的患者数量的增加，对腹膜透析（PD）作为治疗选择的需求也在增加。

例如，根据 CDC 2023 报告，14% 的美国成年人（即 355 亿人）患有慢性肾臟病 (CKD)。盛行率因年龄、种族和民族而异。 CKD 在 65 岁或以上人群 (34%)、非西班牙裔黑人成年人 (20%) 和女性 (14%) 中更为常见。它在非西班牙裔亚洲人或白人成年人中也更为普遍。

此外，2023 年 ISN-GKHA 报告估计，约有 8,500 亿人受到 CKD 的影响。来自弱势群体的人面临更高的风险。

缺乏熟练的专业人员

腹膜透析（PD）设备的市场成长受到严格的政府法规、不断增加的技术故障、疝气和导管堵塞等併发症以及缺乏熟练专业人员的阻碍。此外，老年族群的接受度和认知度较低以及 PD 循环者的认知度较低也是促成因素。

细分市场分析

全球腹膜透析市场根据产品类型、治疗类型、最终用户和地区进行细分。

该产品类型细分市场的腹膜透析解决方案约占腹膜透析市场份额的43.3%

此产品类型细分市场的腹膜透析溶液占比约为43.3%。腹膜透析液（也称为透析液）对于治疗末期肾病 (ESRD) 或严重慢性肾病 (CKD) 患者至关重要。这些含有电解质、葡萄糖和其他渗透剂的液体会透过导管引入腹膜腔，作为半透过滤器。透析液的主要功能是从血液中吸收废物、多余的液体和毒素。溶液中葡萄糖的浓度显着影响液体去除和废物清除效率。

例如，2024 年3 月，印度医疗保健产业知名品牌、总部位于法里达巴德的Mitra Industries 推出了最新创新产品——具有接近中性pH 值和低葡萄糖降解产物(GDP) 的三室腹膜透析(PD) 袋。这项突破性产品旨在彻底改变腹膜透析患者的照护方式，腹膜透析是慢性肾臟病 (CKD) 患者的重要疗法。

市场地理分析

预计北美在整个预测期内将占据总市场份额的 38.4% 左右

由于肾衰竭和慢性肾臟疾病的盛行率不断增加，加上医疗保健成本的上升、政府的努力和可支配收入的增加，预计北美将在整个预测期内占据约 38.4% 的总市场份额。。此外，糖尿病和肥胖会导致肾臟疾病。

例如，根据美国国家糖尿病和消化性肾病研究所的数据，超过七分之一的美国成年人（估计有370 亿美国人）患有慢性肾病(CKD)。人来说，这是两个最常见的原因肾臟疾病——CKD 的风险更大。近三分之一的糖尿病患者和五分之一的高血压患者有肾臟疾病。

Peritoneal dialysis is a treatment for kidney failure, where the kidneys cannot filter blood effectively. It involves a cleansing fluid flowing through a tube into the stomach area, or abdomen, where the peritoneum acts as a filter. After a set time, the filtered fluid is discarded. Peritoneal dialysis differs from hemodialysis, which filters blood outside the body in a machine. Treatments can be done at home, work, or while traveling, but not everyone with kidney failure can benefit from this treatment. Skilled hand care and a trusted caregiver are required for successful peritoneal dialysis.

Market Dynamics: Drivers & Restraints

Rise in the prevalence of chronic kidney diseases

The rising incidence of ESRD and CKD worldwide is one of the primary drivers. As the number of patients requiring dialysis grows, the demand for peritoneal dialysis (PD) as a treatment option also increases.

For instance, according to the CDC 2023, reports that 14% of US adults, or 35.5 billion people, have chronic kidney disease (CKD). The prevalence varies by age, race, and ethnicity. CKD is more common in those aged 65 or older (34%), non-Hispanic Black adults (20%), and women (14%). It is also more prevalent in non-Hispanic Asian or White adults.

Moreover, the 2023 ISN-GKHA report estimates that approximately 850 billion people are affected by CKD. People from disadvantaged populations are at higher risk.

Lack of skilled professionals

The market growth of peritoneal dialysis (PD) devices is hindered by stringent government regulations, increasing technical failures, complications like hernias and catheter blockages, and a lack of skilled professionals. Additionally, low acceptance and awareness among the senior population and low awareness of PD cyclers are also contributing factors.

Market Segment Analysis

The global peritoneal dialysis market is segmented based on product type, treatment type, end user, and region.

The peritoneal dialysis solutions from the product type segment accounted for approximately 43.3% of the peritoneal dialysis market share

The peritoneal dialysis solutions from the product type segment accounted for approximately 43.3%. Peritoneal dialysis solutions, also known as dialysates, are essential in treating patients with end-stage renal disease (ESRD) or severe chronic kidney disease (CKD). These fluids, containing electrolytes, glucose, and other osmotic agents, are introduced into the peritoneal cavity through a catheter, acting as a semi-permeable filter. The primary function of the dialysis solution is to draw waste products, excess fluids, and toxins from the blood. The concentration of glucose in the solution significantly influences fluid removal and waste clearance efficiency.

For instance, in March 2024, Faridabad-based Mitra Industries, a renowned name in India's healthcare industry, unveiled its latest innovation- a triple-chambered peritoneal dialysis (PD) bag with a near-neutral pH and low glucose degradation products (GDPs). This groundbreaking product aims to revolutionize patient care for those undergoing peritoneal dialysis, a crucial therapy for Chronic Kidney Disease (CKD) patients.

Market Geographical Analysis

North America is estimated to hold about 38.4% of the total market share throughout the forecast period

North America is estimated to hold about 38.4% of the total market share throughout the forecast period due to the increasing prevalence of kidney failures and chronic kidney diseases, along with rising healthcare costs, government efforts, and disposable income, contribute to the growth of the industry. Additionally, diabetes and obesity contribute to kidney disorders.

For instance, according to National Institute of Diabetes and Digestive Kidney Diseases, Chronic kidney disease (CKD) affects more than 1 in 7 U.S. adults-an estimated 37 billion Americans.1 For Americans with diabetes or high blood pressure-the two most common causes of kidney disease-the risk for CKD is even greater. Nearly 1 in 3 people with diabetes and 1 in 5 people with high blood pressure have kidney disease.1 Other risk factors for developing kidney disease include heart disease and a family history of kidney failure.

Market Segmentation

By Product Type

Peritoneal Dialysis Solutions

Peritoneal Dialysis Machines

Peritoneal Dialysis Catheters

Dialysis Sets

Others

By Treatment Type

Automated Peritoneal Dialysis (APD)

Continuous Ambulatory Peritoneal Dialysis (CAPD)

By End User

Homecare Settings

Hospitals

Others

By Region

North America

U.S.

Canada

Mexico

Europe

Germany

France

Italy

Spain

Rest of Europe

South America

Brazil

Argentina

Rest of South America

Asia-Pacific

China

India

Japan

South Korea

Rest of Asia-Pacific

Middle East and Africa

Market Competitive Landscape

The major global players in the market include Baxter International Inc, Fresenius Medical Care AG & Co. KGaA, Medtronic plc, Nipro Corporation, DaVita Inc., Diaverum, B. Braun Melsungen AG, Asahi Kasei Corporation, Huaren Pharmaceutical, Co., Ltd, NxStage Medical, Inc among others.

Key Developments

In June 2023, AWAK Technologies (AWAK) and Singapore General Hospital (SGH) announced the launch of a pre-pivotal clinical trial with the enrolment of their first subject to study the safety and efficacy of an improved Automated Wearable Artificial Kidney Peritoneal Dialysis (AWAK PD) device. AWAK PD is a wearable and ultra-portable peritoneal dialysis (PD) system that allows patients with end-stage kidney disease to have dialysis on the go and has been granted 'Breakthrough Device Designation' by the US Food and Drug Administration (FDA).

Why Purchase the Report?

To visualize the global peritoneal dialysis market segmentation based on product type, treatment type, end user, and region as well as understand key commercial assets and players.

Identify commercial opportunities by analyzing trends and co-development.

Excel data sheet with numerous data points of the peritoneal dialysis market level with all segments.

PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.

Product mapping available as excel consisting of key products of all the major players.

The global peritoneal dialysis market report would provide approximately 64 tables, 61 figures, and 186 pages.

Target Audience 2024

Manufacturers/ Buyers

Industry Investors/Investment Bankers

Research Professionals

Emerging Companies

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Product Type
3.2. Snippet by Treatment Type
3.3. Snippet by End User
3.4. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Rise in the prevalence of chronic kidney diseases
  - 4.1.1.2. Rise in the advancements of devices
- 4.1.2. Restraints
  - 4.1.2.1. Lack of skilled professionals
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Patent Analysis
5.6. PESTLE Analysis
5.7. SWOT Analysis
5.8. DMI Opinion

6. By Product Type

6.1. Introduction
- 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 6.1.2. Market Attractiveness Index, By Product Type
6.2. Peritoneal Dialysis Solutions*
- 6.2.1. Introduction
6.3. Peritoneal Dialysis Machines
6.4. Peritoneal Dialysis Catheters
6.5. Dialysis Sets
6.6. Others

7. By Treatment Type

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment Type
- 7.1.2. Market Attractiveness Index, By Treatment Type
7.2. Automated Peritoneal Dialysis (APD)*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Continuous Ambulatory Peritoneal Dialysis (CAPD)

8. By End User

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 8.1.2. Market Attractiveness Index, By End User
8.2. Homecare Settings*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Hospitals
8.4. Others

9. By Region

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 9.1.2. Market Attractiveness Index, By Region
9.2. North America
- 9.2.1. Introduction
- 9.2.2. Key Region-Specific Dynamics
- 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment Type
- 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.2.6.1. U.S.
  - 9.2.6.2. Canada
  - 9.2.6.3. Mexico
9.3. Europe
- 9.3.1. Introduction
- 9.3.2. Key Region-Specific Dynamics
- 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment Type
- 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.3.6.1. Germany
  - 9.3.6.2. UK
  - 9.3.6.3. France
  - 9.3.6.4. Italy
  - 9.3.6.5. Spain
  - 9.3.6.6. Rest of Europe
9.4. South America
- 9.4.1. Introduction
- 9.4.2. Key Region-Specific Dynamics
- 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment Type
- 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.4.6.1. Brazil
  - 9.4.6.2. Argentina
  - 9.4.6.3. Rest of South America
9.5. Asia-Pacific
- 9.5.1. Introduction
- 9.5.2. Key Region-Specific Dynamics
- 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment Type
- 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.5.6.1. China
  - 9.5.6.2. India
  - 9.5.6.3. Japan
  - 9.5.6.4. South Korea
  - 9.5.6.5. Rest of Asia-Pacific
9.6. Middle East and Africa
- 9.6.1. Introduction
- 9.6.2. Key Region-Specific Dynamics
- 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment Type
- 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

10. Competitive Landscape

10.1. Competitive Scenario
10.2. Market Positioning/Share Analysis
10.3. Mergers and Acquisitions Analysis

11. Company Profiles

11.1. Baxter International Inc*
- 11.1.1. Company Overview
- 11.1.2. Product Portfolio and Description
- 11.1.3. Financial Overview
- 11.1.4. Key Developments
11.2. Fresenius Medical Care AG & Co. KGaA
11.3. Medtronic plc
11.4. Nipro Corporation
11.5. DaVita Inc.
11.6. Diaverum
11.7. B. Braun Melsungen AG
11.8. Asahi Kasei Corporation
11.9. Huaren Pharmaceutical Co., Ltd.
11.10. NxStage Medical, Inc (*LIST NOT EXHAUSTIVE)